搜尋結果
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
CNBC· 3 日前Sales of AbbVie's Humira are plummeting as the once-top-selling drug fights competition ... ...
Wegovy maker Novo Nordisk down 4%, heads for worst day since October
CNBC· 13 小時前Novo Nordisk, which also makes diabetes treatment Ozempic, said the rise in sales had offset
Wall St ends sharply higher, US jobs data strengthens case for rate cuts
Reuters· 6 小時前Wall Street surged to a higher close on Friday as a softer-than-expected ...
Forbes Daily: Weed Stocks Light Up After DEA Reclassification
Forbes· 3 日前The U.S. Drug Enforcement Administration will end its ban on cannabis ...
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
CNBC· 4 日前A federal judge in New Jersey on Monday rejected Johnson & Johnson's and Bristol Myers ... ...
Pot Stocks Surge on Report DEA Set to Reclassify Marijuana
Bloomberg· 3 日前Have a confidential tip for our reporters? Shares of cannabis-related companies jumped Tuesday ...
More drugs found on Hong Kong arrivals in first 4 months of year than during 2023
South China Morning Post· 5 日前No drugs were found on passengers in 2021, when strict travel restrictions reduced arrivals to ...
Morning Bid: Fed QT taper calms the horses, yen pops again
Reuters· 2 日前It may be thin gruel after a predictably hawkish Fed meeting that showed little inclination ...
Oh, Canada: U.S. Patients Don't Want Your Health Policies
Forbes· 5 日前There's never been a worse time to get sick in Canada. The Canadian government has ... ...
Stocks making the biggest moves premarket: Apple, Amgen, Cloudflare and more
CNBC· 13 小時前Shares of the chocolate confectionary maker added about 1% after Hershey posted a ...